Biofrontera Inc. to Present at the 34th Annual Roth Conference

Rhea-AI Summary

Biofrontera Inc. (Nasdaq: BFRI) has announced that CEO Erica Monaco will present at the 34th Annual Roth Conference from March 13-15, 2022, in Laguna Niguel, California. During the event, scheduled for March 15 at 11:00 AM PT, Monaco will engage with registered investors through meetings and presentations. The conference features various growth sector discussions, including healthcare and technology. A live audio webcast of Biofrontera's presentation will be accessible on the company's investor relations website.

WOBURN, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, announces today that Erica Monaco, Chief Executive Officer, will be presenting and meeting with registered investors at the 34^th Annual Roth Conference being held March 13-15 in Laguna Niguel, California.

Event:	34th Annual Roth Conference
Date:	Tuesday, March 15, 2022
Presentation Time:	11:00 AM Pacific Time (2:00 PM Eastern Time)
Location:	The Ritz-Carlton, Laguna Niguel, California

The conference will consist of 1-on-1 / small-group meetings, analyst-selected fireside chats, thematic industry panels and on-demand presentations by executive management from approximately 400 private and public companies in a variety of growth sectors including: Blockchain/Cryptocurrency, Business Services, Consumer / Health & Wellness, Healthcare, Resources: Oil & Gas / Meals & Mining, Technology & Media and Sustainability/ESG.

To learn more and submit a registration request, visit https://ibn.fm/ROTH2022Registration. A live audio webcast and replay of Biofrontera’s presentation will be available in the investor relations section of the Company’s website at https://investors.biofrontera-us.com.

About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

# # #

FAQ

When is Biofrontera presenting at the 34th Annual Roth Conference?

Biofrontera will present on March 15, 2022, at 11:00 AM Pacific Time.

Where is the 34th Annual Roth Conference being held?

The conference is taking place at The Ritz-Carlton, Laguna Niguel, California.

What will be discussed during Biofrontera's presentation?

The presentation will discuss Biofrontera's dermatological products and future plans.

How can investors access Biofrontera's presentation?

Investors can access the live audio webcast on Biofrontera's investor relations website.

What is the focus of Biofrontera as a biopharmaceutical company?

Biofrontera specializes in dermatological products, particularly photodynamic therapy and topical antibiotics.